Peer Review History
| Original SubmissionJanuary 3, 2022 |
|---|
|
PONE-D-22-00159Chatbot-based serious games: a useful tool for training medical students? A randomized controlled trial.PLOS ONE Dear Dr. Planquette, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Elsayed Abdelkreem, MD, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Funding Section of your manuscript: “The CHATPROGRESS trial was designed by BP and BR and the protocol was approved by Paris Descartes University’s teaching committee (GF, CB, GM, NR); students were free to refuse to participate to the study. The CHATPROGRESS trial was held in partnership with “Accompagnement à la Gestion de l’Innovation pour la Réussite des étudiants – AGIR" (EJ) and was funded by the 2018 academic grant “Sauver la vie” from Paris Descartes’ Foundation (ES, GF).” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The CHATPROGRESS trial was held in partnership with “Accompagnement à la Gestion de l’Innovation pour la Réussite des étudiants – AGIR" and was funded by the 2018 academic grant “Sauver la vie” from Paris Descartes’ Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 6. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"" files. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors implemented a new teaching platform related to the game-based learning method in teaching medicine which is a good tool that is of help in the engagement of the students in the learning process. Introduction: is satisfactory Aim of the work: The authors mentioned that their aim statement aims to evaluate the benefit of chatbots’ on students’ success rate in their end-term exams, as well as their level of satisfaction. Methods Study population: They implemented their trial on two batches of students; It is better to compare the achievement of the two baches to each other and evaluate their responses separately to evaluate the program's durability on two different occasions. Moreover, It was better to implement more than one course regarding the same bach. Chatprogess program: it is better to mention the link to the program's free trial to be tested by the readers. The authors should include the component of the satisfaction survey in detail and mention if is it validated or not and the method of validation. Results: are satisfactory Discussion: satisfactory with minor comments. The authors should discuss why not all assigned students are not involved in the games and explain the cause of their withdrawal. Moreover, explain the low percentage of students who came to fill the survey Reviewer #2: Thank you for the opportunity to review the manuscript. I found that the study is interesting. Hence, I have several comments to further improve the quality of the paper. Introduction 1. “Developing new teaching strategies…”. I don’t think that this is the common goal as we (the educators) do not want to flood the practice with various strategies. Supposedly “developing an effective teaching strategies…” 2. “Robotized clinical vignettes…” is it using robot? There is a different between robotized and AI-computerized/AI-powered/automated, which in the case of the citation you provide, not using robot. As there are several interpretations on what robot is. For a safer term, perhaps you can use “technology-application clinical vignettes”. 3. “an intensive care unit…” use “etc.” rather than “…” 4. The introduction is insufficient. There argument provided is less robust. The authors need to include more literature and provide argument to justify the needs of the current study. Example of literature should be included: • Chang, C.-Y., Kuo, S.-Y., & Hwang, G.-H. (2022). Chatbot-facilitated Nursing Education: Incorporating a Knowledge-Based Chatbot System into a Nursing Training Program. Educational Technology & Society, 25(1), 15–27. https://www.jstor.org/stable/48647027 • Okonkwo, C.W. & Ade-Ibijola, A. (2021). Chatbots applications in education: A systematic review, Computers and Education: Artificial Intelligence, 2, 100033. https://doi.org/10.1016/j.caeai.2021.100033 • Frangoudes et al. (2021). An Overview of the Use of Chatbots in Medical and Healthcare Education. Learning and Collaboration Technologies: Games and Virtual Environments for Learning: 8th International Conference, 170–184. https://doi.org/10.1007/978-3-030-77943-6_11 Methods 1. You need to explicitly mention that your study is only post-test of RCT. 2. Explanation on how the students were randomized into group needs to be moved from data analysis to study population (where you mentioned about randomization) section. 3. There is no description on the satisfaction survey. The author should explain either the survey is standardized or build by the researcher purposely for the study (if purposely build, then need to tell how it was developed; by discussion? Based on previous literature review?, and how the validity of the questionnaire is ensured), tell on how many questions available, assess on what (the domains), how to answer each question (by Likert scale, dichotomous Yes/No answer), and how long the duration required to complete the questionnaire. 4. Is there any strategy use to encourage the experiment group to utilize the chatbot? Please describe. 5. What strategy you use to ensure optimal response for your participants to answer the survey? When the survey given? Is there reminder provided? How many blasts? How long the duration given for them to complete the survey? 6. “Information regarding students’ interactions with the robot…” please change robot to chatbot or game. 7. Why you use Mann-Whitney U test instead of Independent t-test? Please provide justification to support. 8. Please refer to the CONSORT checklist when preparing for your revised manuscript to ensure the comprehensiveness of information. Result 1. The 171 samples in the experiment group consist of only 104 using the chatbot and the remaining of 67 never use it. So, you cannot analyze the outcome using the 171. The 67 is considered as dropout and cannot be included in the final analysis. The reason is the 67 samples never access to the chatbot and considered no different than those in control group. It is either you move the 67 to control group or exclude them from the analysis. If possible, please use CONSORT flowchart for your figure 2. 2. Again, your analysis on the PCC exam results needs to consider the above point I argued. 3. The difference although significant but small. You need to conduct additional statistical analysis such as effect size and minimal detectable change/minimum clinically important analysis to support your findings. Discussion 1. You mentioned the limitation on the low adherence, but there is no direct discussion about why there is a significant number of students never use the chatbot. 2. You mentioned the limitation on the low response rate but there is no discussion about why on the low response rate on the survey. 3. “Our results showed that using Chatprogress, a chatbot system, improved students’ results on an academic test.” I less agree with the statement as it needs to be cautiously accepted. Although significant, but the visual analysis (mean comparison) shows little difference and no significant correlation between the frequency of chatbot use with grades. I suggest changing to a more cautious tone such as “potentially improved” or “plausible in improving”. 4. More aspect on the feasibility can be discussed as the survey findings yielded several interesting issues. For example, the same game (e.g., I, III) is rated in both as like the most and least. Another example is game II and V has no participant complete rounds. 5. Another interesting aspect is high number intentionally get GO (Game Over), is it because they just want to quickly get the answer (information reading) rather than playing the game? You touched about this in brief as “learning on the platform is done through trial and error, a well-known and efficient learning method”. However, a deeper analysis is required. Is it perhaps playing game is time consuming, so they quickly want the answer? So, they can use the save time for something else? Please add more reference and argument. 6. “This suggests that students were not merely guessing their answers but were genuinely thinking the questions through”. I found this argument is weak if want to be based on high number of voluntary GO. It can be that they do not want to think at all and terminate the game to directly get answer/reasoning? 7. I am not sure if cross-over is limited. Even with 15.9% (n=27) response rate, there is an 11% answered YES that they make anyone else try the CHATPROGRESS. There is a significant non-response bias to be considered. Moreover, you cannot sure that they at least not discuss about the information with their friends (not about using the chatbot, but sharing the knowledge they gained from it). 8. “Similarly, only 13% of the Gamers completed the survey”. 13% or 15.9%? as it is contradicted between the one mentioned in the discussion and the one reported in the result. 9. You need to critically discuss that student motivation to pass exam is multifactorial, not just about using the game. Therefore, this may explain of why there is only a small difference between the experiment and control outcome. Moreover, the use of game perhaps gave an opportunity bias as the intensity is not properly controlled and similarly levelled (example, the experiment group has double the time for revision – from book and game). Biases and limitation of using RCT in medical education research need to be properly discussed. 10. If possible, include more reference and provide a deep discussion. My condolences to your team and family of Professor Guy Meyer. I believe he will be proud with the work. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ayman Z. Elsamanoudy Reviewer #2: Yes: Muhammad Hibatullah Romli ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-00159R1Chatbot-based serious games: a useful tool for training medical students? A randomized controlled trial.PLOS ONE Dear Dr. Planquette, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it the revised version is markedly better, but some minor issues remain to be addressed. First, in abstract "The primary aim was to demonstrate an increase in..", "Secondary aims were to demonstrate an increase in scores..". Authors are encouraged to replace "demonstrate" by another term, such as evaluate or assess, and change the rest of the sentence accordingly.Second, authors are encouraged to further discuss the low response rate following reviewer's comments Please submit your revised manuscript by Dec 12 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Elsayed Abdelkreem, MD, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Thank you so much for addressing my comments and I found the article has been improved. If I may suggest, perhaps in your limitation "The relatively weak adherence of students to the trial and the survey." you need to add another point where you only did sent out the survey once and no particular strategy was implemented to encourage students to answer the questionnaire, then suggest what strategy can be used to enhance response for future research. Perhaps you can write something as "We only blast the survey once without any reminder or incentive provided. Hence, at least a subsequent reminder is required after the initial survey sent or incentive provided may increase the response rate [XX]. However, due to [your reasons] abstain us from doing such strategies." Reference: Sammut, D. R., Griscti, D. O., & Norman, P. I. J. (2021). Strategies to improve response rates to web surveys: A literature review. International Journal of Nursing Studies, 123, 104058. doi:10.1016/j.ijnurstu.2021.104058 ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Ayman Zaky Elsamanoudy Reviewer #2: Yes: Muhammad Hibatullah Romli ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Chatbot-based serious games: a useful tool for training medical students? A randomized controlled trial. PONE-D-22-00159R2 Dear Dr. Planquette, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Elsayed Abdelkreem, MD, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-00159R2 Chatbot-based serious games: a useful tool for training medical students? A randomized controlled trial. Dear Dr. Planquette: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Elsayed Abdelkreem Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .